HCW BIOLOGICS INC
HCWB · NASDAQ
更新於 2026-10-13 15:23:11
- 今日最高
- $1.45
- 今日最低
- $1.30
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
K線圖趨勢，實際資料以交易頁為準
關鍵數據
- 昨天開盤價
- $1.56
- 昨天收盤價
- $1.48
- 成交量
- 42.97K
- 市值
- $3.3M
- 市盈率（P/E）
- --
- 每股收益（EPS）
- $-10.91
昨天價格區間
52週價格區間
公司概況
- 板塊
- HEALTHCARE
- 行業
- Biotechnology
- 子行業
- BIOTECHNOLOGY
- 總部
- 2929 NORTH COMMERCE PARKWAY, MIRAMAR, FL, UNITED STATES, 33025
- 國家
- US
- 上市日期
- 2021-07-20
- 財年截止
- December
- 流通股數
- 1.6M
- CIK
- 0001828673
- 官方網址
- hcwbiologics.com
HCW Biologics Inc is a forward-thinking biotechnology company focused on pioneering immunotherapies and vaccine technologies to tackle pressing health issues such as cancer and infectious diseases. Utilizing its proprietary platforms to amplify immune responses, HCW Biologics is actively expanding a promising pipeline of clinical candidates poised to make significant impacts in patient care. With a keen commitment to strategic partnerships and addressing urgent medical needs, the company aims to establish itself as a competitive force in the biotechnology landscape, presenting compelling investment opportunities that align with the evolving dynamics of the healthcare sector.
財務指標
營業收入
2026-06-30
$135.56K
2026-03-31
$6.54M
2025-12-31
$27.01K
2025-09-30
$15.6K
營業支出
2026-06-30
$3.07M
2026-03-31
$3.28M
2025-12-31
$2.95M
2025-09-30
$3.27M
淨利潤
2026-06-30
-$5.21M
2026-03-31
$4.13M
2025-12-31
$719.23K
2025-09-30
-$4.55M
淨利潤率
2026-06-30
-3.84K%
2026-03-31
63.16%
2025-12-31
2.66K%
2025-09-30
-29.18K%
每股收益
2026-06-30
$-10.10
2026-03-31
$2.22
2025-12-31
$-6.12
2025-09-30
$-12.12
息稅折舊攤銷前利潤
2026-06-30
-$4.97M
2026-03-31
$3.83M
2025-12-31
$1.1M
2025-09-30
-$4.23M
有效稅率
2026-06-30
-195.28%
2026-03-31
-8.68%
2025-12-31
--
2025-09-30
--
| 項目 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| 營業收入 | $135.56K | $6.54M | $27.01K | $15.6K |
| 營業支出 | $3.07M | $3.28M | $2.95M | $3.27M |
| 淨利潤 | -$5.21M | $4.13M | $719.23K | -$4.55M |
| 淨利潤率 | -3.84K% | 63.16% | 2.66K% | -29.18K% |
| 每股收益 | $-10.10 | $2.22 | $-6.12 | $-12.12 |
| 息稅折舊攤銷前利潤 | -$4.97M | $3.83M | $1.1M | -$4.23M |
| 有效稅率 | -195.28% | -8.68% | -- | -- |
常見問題
風險提示
股價可能大幅波動，短時間內可能出現顯著漲跌。 數位資產與衍生性商品交易可能涉及槓桿、流動性等額外風險。 本頁內容僅供參考，不構成任何投資建議。 產品可用性與訪問可能因地區及適用法規而異。